| # | Title | Journal | Year | Citations |
|---|
| 1 | Managing Addiction as a Chronic Condition | Addiction Science & Clinical Practice | 2007 | 292 |
| 2 | Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review | Addiction Science & Clinical Practice | 2016 | 231 |
| 3 | Marijuana Dependence and Its Treatment | Addiction Science & Clinical Practice | 2007 | 228 |
| 4 | Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors | Addiction Science & Clinical Practice | 2012 | 218 |
| 5 | Dialectical Behavior Therapy for Substance Abusers | Addiction Science & Clinical Practice | 2008 | 197 |
| 6 | Mindfulness-based treatment of addiction: current state of the field and envisioning the next wave of research | Addiction Science & Clinical Practice | 2018 | 181 |
| 7 | Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach | Addiction Science & Clinical Practice | 2013 | 171 |
| 8 | Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff | Addiction Science & Clinical Practice | 2018 | 162 |
| 9 | Mobile phone brief intervention applications for risky alcohol use among university students: a randomized controlled study | Addiction Science & Clinical Practice | 2014 | 153 |
| 10 | Challenges in Using Opioids to Treat Pain in Persons With Substance Use Disorders | Addiction Science & Clinical Practice | 2008 | 153 |
| 11 | Review of the assessment and management of neonatal abstinence syndrome | Addiction Science & Clinical Practice | 2014 | 125 |
| 12 | The case for considering quality of life in addiction research and clinical practice | Addiction Science & Clinical Practice | 2011 | 124 |
| 13 | Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know | Addiction Science & Clinical Practice | 2017 | 121 |
| 14 | Addiction and cognition | Addiction Science & Clinical Practice | 2010 | 120 |
| 15 | Emergency department screening and interventions for substance use disorders | Addiction Science & Clinical Practice | 2018 | 118 |
| 16 | A conceptual model for understanding post-release opioid-related overdose risk | Addiction Science & Clinical Practice | 2019 | 106 |
| 17 | Designer drugs 2015: assessment and management | Addiction Science & Clinical Practice | 2015 | 99 |
| 18 | Trends in telemedicine use in addiction treatment | Addiction Science & Clinical Practice | 2015 | 94 |
| 19 | Motivation rulers for smoking cessation: a prospective observational examination of construct and predictive validity | Addiction Science & Clinical Practice | 2012 | 93 |
| 20 | Physician versus non-physician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: the ADVISe cluster randomized controlled implementation trial | Addiction Science & Clinical Practice | 2015 | 87 |
| 21 | Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications | Addiction Science & Clinical Practice | 2011 | 87 |
| 22 | Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments | Addiction Science & Clinical Practice | 2011 | 86 |
| 23 | Substance use disorders and risk of suicide in a general US population: a case control study | Addiction Science & Clinical Practice | 2020 | 76 |
| 24 | Screening for adolescent alcohol and drug use in pediatric health-care settings: predictors and implications for practice and policy | Addiction Science & Clinical Practice | 2012 | 74 |
| 25 | The good behavior game and the future of prevention and treatment | Addiction Science & Clinical Practice | 2011 | 71 |
| 26 | Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders | Addiction Science & Clinical Practice | 2015 | 69 |
| 27 | Can screening and brief intervention lead to population-level reductions in alcohol-related harm? | Addiction Science & Clinical Practice | 2012 | 67 |
| 28 | Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders | Addiction Science & Clinical Practice | 2019 | 67 |
| 29 | Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder | Addiction Science & Clinical Practice | 2015 | 66 |
| 30 | Stigma associated with medication treatment for young adults with opioid use disorder: a case series | Addiction Science & Clinical Practice | 2018 | 65 |
| 31 | Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco | Addiction Science & Clinical Practice | 2019 | 65 |
| 32 | Validation of the AUDIT-C in adults seeking help with their drinking online | Addiction Science & Clinical Practice | 2017 | 64 |
| 33 | Inhalant use and inhalant use disorders in the United States | Addiction Science & Clinical Practice | 2011 | 64 |
| 34 | Smartphone apps for managing alcohol consumption: a literature review | Addiction Science & Clinical Practice | 2020 | 63 |
| 35 | Interventions to Promote Successful Re-Entry Among Drug-Abusing Parolees | Addiction Science & Clinical Practice | 2009 | 58 |
| 36 | Alcohol consumption patterns and HIV viral suppression among persons receiving HIV care in Florida: an observational study | Addiction Science & Clinical Practice | 2017 | 56 |
| 37 | Public sector low threshold office-based buprenorphine treatment: outcomes at year 7 | Addiction Science & Clinical Practice | 2017 | 55 |
| 38 | Acceptability of a mobile health intervention to enhance HIV care coordination for patients with substance use disorders | Addiction Science & Clinical Practice | 2017 | 55 |
| 39 | Technology-based interventions for tobacco and other drug use in university and college students: a systematic review and meta-analysis | Addiction Science & Clinical Practice | 2015 | 54 |
| 40 | Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach | Addiction Science & Clinical Practice | 2018 | 54 |
| 41 | Screening, treatment initiation, and referral for substance use disorders | Addiction Science & Clinical Practice | 2017 | 53 |
| 42 | Prevalence and co-use of marijuana among young adult cigarette smokers: An anonymous online national survey | Addiction Science & Clinical Practice | 2012 | 51 |
| 43 | HealthCall for the smartphone: technology enhancement of brief intervention in HIV alcohol dependent patients | Addiction Science & Clinical Practice | 2014 | 50 |
| 44 | Addressing Addiction: Concepts and Instruments | Addiction Science & Clinical Practice | 2007 | 50 |
| 45 | Just call it “treatment” | Addiction Science & Clinical Practice | 2012 | 49 |
| 46 | Rethinking alcohol interventions in health care: a thematic meeting of the International Network on Brief Interventions for Alcohol & Other Drugs (INEBRIA) | Addiction Science & Clinical Practice | 2017 | 48 |
| 47 | Levamisole-induced leukocytoclastic vasculitis and neutropenia in a patient with cocaine use: An extensive case with necrosis of skin, soft tissue, and cartilage | Addiction Science & Clinical Practice | 2012 | 47 |
| 48 | Management of chronic pain with chronic opioid therapy in patients with substance use disorders | Addiction Science & Clinical Practice | 2013 | 46 |
| 49 | Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review | Addiction Science & Clinical Practice | 2021 | 46 |
| 50 | Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness | Addiction Science & Clinical Practice | 2016 | 40 |
